Elsevier

Cytokine & Growth Factor Reviews

Volume 51, February 2020, Pages 75-83
Cytokine & Growth Factor Reviews

Tumor-derived extracellular vesicles and microRNAs: Functional roles, diagnostic, prognostic and therapeutic options

https://doi.org/10.1016/j.cytogfr.2019.12.010Get rights and content

Highlights

  • Tumor cells transfer oncogenic activity by exosome release.

  • MiRNAs are loaded into exosomes by selective mechanisms.

  • Exosomal miRNAs communicate with cells of the tumor microenvironment.

  • This interaction influence tumor progression and metastatization.

Abstract

In the last few years cancer research more and more highlighted the importance of cell to cell communication in tumor progression. Among many other functional mechanisms, results evidenced the importance of miRNAs loaded into exosomes and their actions as mediators in intercellular communication, either in the tumor microenvironment or at distant sites. Deregulation of miRNA levels is a prerogative of cancer cells and is reflected in the miRNA cargo of tumor derived exosomes. Thus, learning of circulating miRNA activities add the missing piece we need to understand some unclear aspects of cancer biology.

Here we summarized the current knowledge on exosome transfer capabilities between cancer cells and all the cells constituting tumor microenvironment with a particular focus on their miRNA cargos and regulatory functions. The clinical relevance of these molecular aspects is emphasized by numerous cell interactions that ultimately result in normal cell function defeat, relevant to increase tumor malignancy. The quantitative and qualitative evaluation of circulating miRNAs offers new perspective for better diagnosis and prognosis of cancer patients, eventually improving their management.

Introduction

Growing evidence shows that microvesicles, including exosomes, play an important role in transmitting biological information to proximal and distant sites by carrying and releasing their cargos. Many studies have demonstrated that exosomes can be secreted by all cellular types being able to transfer their specific properties via horizontal propagation, thus EXOs secreted by tumor cells are shown to transfer oncogenic activity, whereas those released by normal cells can be involved in the maintenance of physiological homeostasis.

Among many other transported molecules, miRNAs seem to play a fundamental role possibly because of their small size and direct action. Actually, mature miRNAs are less than 25 nucleotides long and, differently from mRNAs, do not require further maturative steps to exert their biological effects. In addition, each miRNA can regulate the expression of hundreds of mRNAs, and each mRNA can be targeted by several miRNAs, thus producing a complex and powerful regulatory network.

It is important to note that free or EXO-loaded miRNAs secreted in extracellular compartments, as blood and other body fluids, result representative of their producing cells, thus allowing frequent noninvasive analyses. Indeed the endogenously produced and the engineered exosomes will represent important tools with diagnostic and prognostic values as well as therapeutic effectiveness, respectively. Also, the fundamental role acquired by the tumor microenvironment in cancer progression suggests exosomes, in view of their involvement in the intercellular crosstalk, as a promising field whose development would offer novel insights and therapeutic opportunities.

Section snippets

Exosome biogenesis and composition

The term exosome (EXO) is referred to small vesicles (40−150 nm) of endocytic origin released into the extracellular environment by all types of cells, including cancer cells. They originate from the endocytic pathway through different maturation steps and are involved in trafficking of different molecules, including proteins, lipids, coding and non-coding RNAs. EXO precursors consist in intraluminal vesicles (ILVs) formed by internal membrane budding into early endosomes and microvesicular

miRNA biogenesis

MiRNAs are highly conserved single strand regulatory RNAs 20–25 nucleotide long. Their transcription might depend on the host gene regulation, when miRNA sequences are inserted as part of genic intron or exon, but they can also undergo to a direct regulation through their own promoter region. MiRNA transcription is RNA polymerase II dependent to form an immature nuclear pri-miRNA transcript characterized by a 60–120 nucleotide stem loop structure. The Drosha enzyme cleaves the pri-miRNA into

Biological function of miRNAs

Beyond bioinformatics target prediction, animal knockout models and transgenic overexpression experiments revealed the biological function of individual miRNAs. However, redundancy among miRNA family members requires inactivation of more than one member to associate them to a cell phenotypic change or regulatory role [14]. It is now evident that miRNAs play essential roles in nearly all biological processes, including cell development and differentiation. Notably, the failure of the miRNA

miRNAs in Cancer

Gene profiling analyses have evidenced how miRNA expression changes during the different phases of cancer progression, thus revealing their functions in promoting or contrasting cancer evolution. In the literature, a huge number of contributes identified altered miRNA expression in different cancers. Through the modulation of their mRNA targets, miRNA involvement was demonstrated in all the key tumor-associated processes, among others DNA damage repair, cell death, cell proliferation, as well

Exosomal miRNA loading

EXOs can mediate cell-to-cell communication by molecule transfer from donor to recipient cells. The loading process performed by donor cells appears a selective process, but the mechanism of selection remains essentially unsolved. For the first time in 2007, the analysis of total RNAs transported by exosomes, indicated by Valadi and coauthors as “exosomal shuttle mRNAs”, revealed the presence of specific repertoires of both mRNAs and miRNAs [27]. Indeed, among 2588 annotated miRNAs in the human

Diagnostic and prognostic potential of circulating miRNAs

Growing evidence indicates that circulating miRNAs might function as potential biomarkers in different type of cancers. Relevant is the possibility to use them for early diagnosis or for prognosis, associating their detection to different step of tumor progression. In addition miRNA levels could predict tumor recurrence in post-surgery follow-up particularly in those cancers, as for example ovarian cancer, where the early stage detection is challenging due to the absence of specific symptoms [78

Conclusion

Undoubtedly EXOs have opened an important new scenario. Among many other activities, they can be utilized for safe and efficient delivery of anticancer drugs possibly tailored on each single patient. An innovative upgrade of EXO use is the plethora of artificial built nanocarriers that summarize all EXO organotropic properties overcoming their limitation use. In an ideal clinical setting of nanocarriers, we have the advantage of loading them with patient specific anti-cancer drugs avoiding or

Funding

This work was supported by the Italian Ministry of Health.

Declaration of Competing Interest

The authors declare no conflicts of interest.

Dr. Giada Pontecorvi is a PhD student in Morphogenesis and Tissue Engineering at “Sapienza” University of Rome. She is performing her experimental studies at Center for Gender Specific Medicine, Oncology Unit (Istituto Superiore di Sanità, Rome). Her work focuses on melanoma and breast cancer molecular studies.

References (90)

  • D. Koppers-Lalic et al.

    Non templated nucleotide additions distinguish the small RNA composition in cells from exosomes

    Cell Rep.

    (2014)
  • T. Janas et al.

    Mechanisms of RNA loading into exosomes

    FEBS Lett.

    (2015)
  • C. Villarroya-Beltri et al.

    Sorting it out: regulation of exosome loading

    Semin. Cancer Biol.

    (2014)
  • M. Katakowski et al.

    Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth

    Cancer Lett.

    (2013)
  • D.W. Greening et al.

    Exosomes and their roles in immune regulation and cancer

    Semin. Cell Dev. Biol.

    (2015)
  • X. Chen et al.

    Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype

    Cancer Lett.

    (2018)
  • P. Kanlikilicer et al.

    Exosomal miRNA confers chemoresistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer

    EBioMedicine

    (2018)
  • J. Zhou et al.

    Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo

    Exp. Cell Res.

    (2018)
  • B. Kulkarni et al.

    Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer

    Drug Discov. Today

    (2019)
  • L. Zhao et al.

    The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance

    Cancer Lett.

    (2015)
  • F. Yang et al.

    Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts

    Mol. Cancer

    (2017)
  • J. Ding et al.

    Exosome-mediated miR-222 transferring: an insight into NF-κB-mediated breast cancer metastasis

    Exp. Cell Res.

    (2018)
  • A. Singh et al.

    Epigenetic biomarkers in the management of ovarian Cancer: current prospectives

    Front. Cell Dev. Biol.

    (2019)
  • S. Guraya

    Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis

    Int. J. Surg.

    (2018)
  • W. Zhou et al.

    Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis

    Cancer Cell

    (2014)
  • R. Ji et al.

    miR-374a-5p: a new target for diagnosis and drug resistance therapy in gastric Cancer

    Mol. Ther. Nucleic Acids

    (2019)
  • G. Van Niel et al.

    Shedding light on the cell biology of extracellular vesicles

    Nat. Rev. Mol. Cell Biol.

    (2018)
  • D.K. Jeppesen et al.

    Reassessment of exosome composition

    Cell

    (2019)
  • M. Colombo et al.

    Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles

    J. Cell. Sci.

    (2013)
  • K. Trajkovic et al.

    Ceramide triggers budding of exosome vesicles into multivesicular endosomes

    Science

    (2008)
  • I. Nazarenko et al.

    Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation

    Cancer Res.

    (2010)
  • S.I. Buschow et al.

    MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways

    Traffic

    (2009)
  • Y. Zeng

    Principles of micro-RNA production and maturation

    Oncogene

    (2006)
  • K. Saliminejad et al.

    An overview of microRNAs: biology, functions, therapeutics, and analysis methods

    J. Cell. Physiol.

    (2019)
  • E. Bernstein et al.

    Dicer is essential for mouse development

    Nat. Genet.

    (2003)
  • B. Liu et al.

    Interplay between miRNAs and host genes and their role in cancer

    Brief. Funct. Genomics

    (2019)
  • M.S. Masoudi et al.

    MiR-21: A key player in glioblastoma pathogenesis

    J. Cell. Biochem.

    (2018)
  • L.A. Pobezinsky et al.

    Let’s fight cancer: let-7 is a tool to enhance antitumor immune responses

    Future Oncol.

    (2018)
  • G. Ravegnini et al.

    Prognostic role of miR-221 and miR-222 expression in Cancer patients: a systematic review and meta-analysis

    Cancers (Basel)

    (2019)
  • F. Felicetti et al.

    The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms

    Cancer Res.

    (2008)
  • G. Mattia et al.

    Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma

    Pigment Cell Melanoma Res.

    (2011)
  • L. Zhang et al.

    MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

    J. Exp. Clin. Cancer Res.

    (2019)
  • L. Ma et al.

    Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

    Nat. Biotechnol.

    (2010)
  • C. Bouvy et al.

    Circulating MicroRNAs as biomarkers in diffuse large B-cell lymphoma: a pilot prospective longitudinal clinical study

    Biomark. Cancer

    (2018)
  • H. Valadi et al.

    Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

    Nat. Cell Biol.

    (2007)
  • Cited by (0)

    Dr. Giada Pontecorvi is a PhD student in Morphogenesis and Tissue Engineering at “Sapienza” University of Rome. She is performing her experimental studies at Center for Gender Specific Medicine, Oncology Unit (Istituto Superiore di Sanità, Rome). Her work focuses on melanoma and breast cancer molecular studies.

    Dr. Maria Bellenghi is a Researcher at the Center for Gender Specific Medicine, Oncology Unit (Istituto Superiore di Sanità, Rome). She obtained her PhD in Experimental Medicine from “Sapienza” University of Rome in February 2017. Her work focuses on melanoma and breast cancer molecular biology, chiefly on lipid and microRNA functional roles.

    Dr. Rossella Puglisi is a Researcher at the Center for Gender Specific Medicine, Oncology Unit (Istituto Superiore di Sanità, Rome). She obtained her PhD in Science and Cell Technology from “Sapienza” University of Rome in 2001. Her work focuses on melanoma molecular biology with particular experience on histology image analysis. She has authored several publications in highly reputed International journals.

    Dr. Alessandra Carè is the Director of the Center for Gender Specific Medicine (Istituto Superiore di Sanità, Rome). She obtained her Specialty in Medical Genetics from the University of Rome “Sapienza” in 1983. She was previously responsible for the Molecular Oncology section of the Oncology and Molecular Medicine Department focusing her work on melanoma, sarcoma and breast cancer with particular interest on miRNA regulation and exosome functional role. She has authored several publications in highly reputed International journals.

    Dr. Gianfranco Mattia is a Senior Researcher at the Center for Gender Specific Medicine, Oncology Unit (Istituto Superiore di Sanità, Rome). He obtained his Specialty in Biotechnology from University of Rome La Sapienza in 1992. His work focuses on melanoma and breast cancer molecular biology, particularly on molecular histopatology . He has authored several publications in highly reputed International journals.

    View full text